[Remote] MRD Clinical Account Executive, New England at Tempus

Massachusetts, United States

Tempus Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Requirements

Candidates should possess a B.S. in life science, biology, business, or marketing, with an MBA preferred. A proven track record of revenue generation in diagnostics, pharmaceuticals, or biotechnology is essential, along with at least 3 years of direct account management experience in molecular diagnostics, ideally with a focus on MRD testing. Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices is required. The role demands proven ability in consultative selling of integrated molecular diagnostic solutions, comfort engaging with executive-level stakeholders, and an in-depth understanding of the payer and reimbursement environment in oncology diagnostics. Strong independent work ethic, communication, project management, prioritization skills, knowledge of molecular diagnostics and MRD testing, proficiency in Microsoft Office and Salesforce.com, and the ability to develop cross-functional relationships are also necessary. Advanced presentation skills and business acumen are required, with the ability to work effectively with minimal direction.

Responsibilities

The MRD Clinical Account Executive will drive the adoption of Tempus's MRD testing services within their territory, engaging with KOLs, clinicians, and decision-makers to establish and expand business opportunities. Responsibilities include developing strategic plans for client acquisition and retention, maximizing client-bill contracting, and implementing laboratory services agreements. The role involves collaborating with various sales roles to achieve company goals, identifying partnership opportunities, and providing market feedback to leadership. A comprehensive business plan for the territory, including budgets and goal setting, must be developed and implemented. The individual will represent Tempus's company culture with integrity, respect, and trust.

Skills

Precision Medicine
Healthcare Sales
Business Development
Client Relationship Management
Strategic Planning
Territory Management
Market Analysis
Oncology
Minimal Residual Disease (MRD) Testing
Laboratory Services Agreements (LSAs)

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI